kabutan

Delta-Fly Pharma, Inc.(4598) Summary

4598
TSE Growth
Delta-Fly Pharma, Inc.
234
JPY
-2
(-0.85%)
Mar 13, 3:30 pm JST
1.46
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
233.8
Mar 13, 10:06 pm JST
Summary Chart Historical News Financial Result
PER
PBR
13.9
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
230 JPY 1.44 USD
Previous Close Mar 12
236 JPY 1.48 USD
High Mar 13, 10:47 am
236 JPY 1.48 USD
Low Mar 13, 9:50 am
228 JPY 1.43 USD
Volume
227,500
Trading Value
0.05B JPY 0.33M USD
VWAP
231.68 JPY 1.45 USD
Minimum Trading Value
23,400 JPY 146 USD
Market Cap
2.85B JPY 0.02B USD
Number of Trades
268
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly High
1-Year Average
878
1-Year High Dec 10, 2025
15,787
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 2,531,900
Feb 27, 2026 0 2,658,000
Feb 20, 2026 0 2,457,900
Feb 13, 2026 0 2,431,400
Feb 6, 2026 0 2,464,400
Company Profile
Delta-Fly Pharma, Inc. is a bioventure company developing anticancer drugs. The company handles everything from research and development to manufacturing and sales.
Sector
Pharmaceuticals
Delta-Fly Pharma, Inc. is a bioventure company that consistently handles the entire process from research and development to manufacturing and sales of anticancer drugs. Using its proprietary "modular drug discovery" method, the company aims to create new anticancer drugs with an excellent balance of clinical efficacy and safety by combining existing anticancer active substances. With multiple development pipelines, the company is conducting clinical trials targeting recurrent and refractory acute myeloid leukemia, lung cancer, pancreatic cancer, and other conditions. Their business model is based on generating revenue through product sales, milestone payments, and royalty income by out-licensing sales rights to pharmaceutical companies. Focusing on licensing agreements with pharmaceutical companies, Delta-Fly Pharma has established an efficient research and development system by utilizing external resources.